Impact of exposure to alcohol marketing and subsequent drinking patterns among youth and young adults

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the impact of exposure to any form of alcohol marketing, compared to less exposure or no exposure, on alcohol consumption patterns among youth and young adults up to and including the age of 25 years (we want to be able to look at potential dose response relationships at different levels of exposure).

Alcohol Marketing and Youth Drinking: Is There a Causal Relationship, and Why Does It Matter?

“…Two information specialists from the project coordination team developed a general search strategy that would serve to populate four unique systematic reviews on the topic of alcohol marketing and underage drinking. The four systematic reviews are described briefly below: (a) Cochrane review of longitudinal and experimental studies, titled “Impact of exposure to alcohol marketing and subsequent drinking patterns among youth and young adults.” The published protocol ( Cukier et al, 2018 ) includes a summary of previous reviews; a definition of marketing comprising paid, earned, and owned media that aims to cultivate brand allegiance and increase demand for a product; and a theoretical discussion of how marketing could influence underage drinkers; as well as objectives and methods. (b) Cross-sectional studies of exposure to alcohol marketing and its influence on alcohol attitudes ( Henehan & Ross, 2020 , this supplement).…”

“…(a) Cochrane review of longitudinal and experimental studies, titled “Impact of exposure to alcohol marketing and subsequent drinking patterns among youth and young adults.” The published protocol ( Cukier et al, 2018 ) includes a summary of previous reviews; a definition of marketing comprising paid, earned, and owned media that aims to cultivate brand allegiance and increase demand for a product; and a theoretical discussion of how marketing could influence underage drinkers; as well as objectives and methods.…”

“…Another important aspect of determining causality is to show that the exposure precedes the outcome. This criterion places a premium on longitudinal research in which marketing exposures are measured before the onset of the behavior—these studies, along with studies in which marketing exposures were randomly assigned, will be covered in the Cochrane review on the impact of exposure to alcohol marketing ( Cukier et al, 2018 ), the basis for this supplement. Longitudinal observational studies often assess marketing exposure in a cohort of adolescents, starting with never-drinkers and then show the association between exposure at baseline and onset of drinking.…”

“…In 2016, Rutger Engels sponsored a meeting of behavioral scientists in Utrecht, The Netherlands, in which we decided to conduct a Cochrane review of all longitudinal and experimental studies of alcohol marketing and drinking among youth. A team of investigators obtained sponsorship from the appropriate Cochrane review committees and published a protocol ( Cukier et al, 2018 ), which guided subsequent and ongoing efforts both to finish the Cochrane review and to also commission other articles that we deemed important for a scientific summary but out of the scope of the Cochrane review. Those articles were commissioned and discussed at a subsequent 2017 meeting in Atlanta, GA; they include systematic and narrative reviews.…”

Effectiveness of a nurse-led hospital-to-home transitional care intervention for older adults with multimorbidity and depressive symptoms: A pragmatic randomized controlled trial

“…Transitional care interventions have been recommended to enhance coordination and continuity of health care in community-living older adults with complex needs transitioning from hospital to home, and have been linked to decreasing hospital readmissions and other positive outcomes [31,44,[50][51][52][53][54][55][56]. However, these trials have been largely based on transitional care interventions for single conditions, which often excluded patients with multimorbidity or depressive symptoms [57][58][59][60][61].…”